Breakthrough genomic cancer testing from a single blood draw

Guardant Health has helped thousands of oncologists learn accurate and actionable information about tens of thousands of patients, while avoiding the costs and risks of tissue biopsies. Our genomic test helps match advanced-cancer patients to approved targeted therapies as well as drugs in clinical trials.

Trusted by leading oncologists at top cancer centers

Guardant360 is comprehensive and accurate

The most validated comprehensive liquid biopsy

Guardant Health has been used over 70,000 times by more than 5,000 oncologists and at all 27 National Comprehensive Network Cancer Centers. Our clinical research collaborations have resulted in over 70 peer-reviewed publications.